This content is machine translated New therapy study Ruxolitinib against strong inflammatory response Ruxolitinib has been used to treat myeloid diseases of the bone marrow. Experts from the Department of Internal Medicine III at Ulm University Hospital (Germany) are now investigating how corona…
View Post 1 min This content is machine translated CORIMUNO-TOCI Study Significant COVID-19 improvement with tocilizumab. In patients with COVID-19 pneumonia, an immune-mediated “cytokine storm” is thought to lead to acute respiratory failure and death. The CORIMUNO-19 platform was rapidly developed and established to evaluate the…
View Post 2 min This content is machine translated Migraine Common genetic variables to MS detected Although the symptoms and risk factors for migraine and multiple sclerosis (MS) often overlap, it is not known whether these two conditions are independent or share a common biological etiology,…
View Post 6 min This content is machine translated Primary hyperhidrosis Comorbid depression and anxiety disorders are common Excessive sweating is a psychologically stressful symptom. There are empirical findings of an increased prevalence of depressive disorders and/or an anxiety problem in patients with primary hyperhidrosis. This should be…
View Post 3 min This content is machine translated Guselkumab Now also available as a patient-friendly ready-to-use pen The device, which was recently approved by Swissmedic, enables psoriasis sufferers to self-administer the biologic in single doses. It is currently the only IL23 inhibitor available in Switzerland in the…
View Post 3 min This content is machine translated Crateagus extract Not only cardioprotective, but also promotes cardiomyogenesis. On the background of evidence-based positive effects of hawthorn on cardiac muscles, the effect of a standardized special extract on cardiac progenitor cells was investigated in an in vitro study.…
View Post 2 min This content is machine translated Alzheimer's disease Unexpected partial success of clinical trial gives hope The active substance aducanumab was tested in two large phase III trials. Based on new positive efficacy data, the study program, which has been suspended in the meantime, will be continued.
View Post 5 min This content is machine translated Burn Wounds No time to lose is the motto! The risk of hypertrophic scars is higher in burn wounds the longer the healing process takes. Correct diagnostic assessment is the basis for adequate therapy. Whether second-degree burns should be…
View Post 5 min This content is machine translated Metastatic melanoma New approval from the field of molecular precision medicine The targeted combination therapy with encorafenib and binimetinib has recently become available in Switzerland for adults with non-resectable or metastatic melanoma with a BRAFV600 mutation. The approval is based on the…
View Post 4 min This content is machine translated Chronic wounds The next chapter of modern treatment techniques New study results show that canisterless negative pressure wound therapy is superior to the traditional variant of vacuum therapy in terms of reduction of wound area, depth and volume in…
View Post 2 min This content is machine translated Stroke Gentle rehabilitation reduces subsequent disabilities Stroke treatment has improved in recent years to the point where survival rates are increasing. However, many patients do not fully recover functionally. Americans focus on endurance training in rehabilitation.…
